Investigators examined the role that methyltransferase-like 3 (METTL3) plays in pancreatic cancer cell proliferation and stemness. They discovered that in pancreatic cancer cells, METTL3-mediated N6-methyladenosine (m6A) alterations regulate ID2 as a downstream target.
[Cancer Letters]